Cormode, DP, Skajaa, T, Fayad, ZA, Mulder, WJ. Nanotechnology in medical imaging: probe design and applications. Arterioscler Thromb Vasc Biol 2009, 29: 992–1000.
Moghimi, SM, Hunter, AC, Murray, JC. Nanomedicine: current status and future prospects. FASEB J 2005, 19: 311–330.
Peer, D, Karp, JM, Hong, S, Farokhzad, OC, Margalit, R, et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007, 2: 751–760.
Wagner, V, Dullaart, A, Bock, AK, Zweck, A. The emerging nanomedicine landscape. Nat.Biotechnol. 2006, 24: 1211–1217.
Torchilin, VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005, 4: 145–160.
Torchilin, VP. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007, 24: 1–16.
Ansari, MJ, Kohli, K, Dixit, N. Microemulsions as potential drug delivery systems: a review. PDA J Pharm Sci Technol 2008, 62: 66–79.
Bagwe, RP, Kanicky, JR, Palla, BJ, Patanjali, PK, Shah, DO. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Crit Rev Ther Drug Carrier Syst 2001, 18: 77–140.
Vucic, E, Sanders, HM, Arena, F, Terreno, E, Aime, S, et al. Well‐defined, multifunctional nanostructures of a paramagnetic lipid and a lipopeptide for macrophage imaging. J Am Chem Soc 2009, 131: 406–407.
Cormode, DP, Mulder, WJM, Fisher, EA, Fayad, ZA. Modified lipoproteins as contrast agents for molecular imaging. Future Lipidol 2007, 2: 587–590.
Goldberg, M, Langer, R, Jia, X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed 2007, 18: 241–268.
Michalet, X, Pinaud, FF, Bentolila, LA, Tsay, JM, Doose, S, et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307: 538–544.
Bulte, JW, Kraitchman, DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004, 17: 484–499.
Mulder, WJ, Strijkers, GJ, van Tilborg, GA, Cormode, DP, Fayad, ZA, et al. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc Chem Res 2009, 42: 904–914.
Silva, GA. Nanomedicine: seeing the benefits of ceria. Nat Nanotechnol 2006, 4: 92–94.
Boisselier, E, Astruc, D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009, 38: 1759–1782.
Mulder, WJ, Strijkers, GJ, van Tilborg, GA, Griffioen, AW, Nicolay, K. Lipid‐based nanoparticles for contrast‐enhanced MRI and molecular imaging. NMR Biomed 2006, 19: 142–164.
Hyafil, F, Cornily, JC, Feig, JE, Gordon, R, Vucic, E, et al. Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. Nat Med 2007, 13: 636–641.
Morawski, AM, Lanza, GA, Wickline, SA. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr Opin Biotechnol 2005, 16: 89–92.
Mulder, WJ, Cormode, DP, Hak, S, Lobatto, ME, Silvera, S, et al. Multimodality nanotracers for cardiovascular applications. Nat Clin Pract Cardiovasc Med 2008, (suppl 2): S103–S111.
Bailon, P, Won, CY. PEG‐modified biopharmaceuticals. Expert Opin Drug Deliv 2009, 6: 1–16.
McCarthy, JR, Kelly, KA, Sun, EY, Weissleder, R. Targeted delivery of multifunctional magnetic nanoparticles. Nanomedicine 2007, 2: 153–167.
Schiffelers, RM, de Wolf, HK, van, RI, Storm, G. Synthetic delivery systems for intravenous administration of nucleic acids. Nanomed 2007, 2: 169–181.
Hilger, I, Hiergeist, R, Hergt, R, Winnefeld, K, Schubert, H, et al. Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study. Invest Radiol 2002, 37: 580–586.
O`Neal, DP, Hirsch, LR, Halas, NJ, Payne, JD, West, JL. Photo‐thermal tumor ablation in mice using near infrared‐absorbing nanoparticles. Cancer Lett 2004, 209: 171–176.
Mitra, A, Nan, A, Line, BR, Ghandehari, H. Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr Pharm Des 2006, 12: 4729–4749.
Strijkers, GJ, Mulder, WJ, van Tilborg, GA, Nicolay, K. MRI contrast agents: current status and future perspectives. Anticancer Agents Med Chem 2007, 7: 291–305.
Woods, M, Woessner, DE, Sherry, AD. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem Soc Rev 2006, 35: 500–511.
Bulte, JW. Hot spot MRI emerges from the background. Nat Biotechnol 2005, 23: 945–946.
Yu, SB, Watson, AD. Metal‐based X‐ray contrast media. Chem Rev 1999, 99: 2353–2378.
Ntziachristos, V, Ripoll, J, Wang, LV, Weissleder, R. Looking and listening to light: the evolution of whole‐body photonic imaging. Nat Biotechnol 2005, 23: 313–320.
Huber, MM, Staubli, AB, Kustedjo, K, Gray, MH, Shih, J, et al. Fluorescently detectable magnetic resonance imaging agents. Bioconjug Chem 1998, 9: 242–249.
Mulder, WJ, Griffioen, AW, Strijkers, GJ, Cormode, DP, Nicolay, K, et al. Magnetic and fluorescent nanoparticles for multimodality imaging. Nanomed 2007, 2: 307–324.
Frullano, L, Meade, TJ. Multimodal MRI contrast agents. J Biol Inorg Chem 2007, 12: 939–949.
Schipper, ML, Cheng, Z, Lee, SW, Bentolila, LA, Iyer, G, et al. microPET‐based biodistribution of quantum dots in living mice. J Nucl Med 2007, 48: 1511–1518.
Mulder, WJ, Koole, R, Brandwijk, RJ, Storm, G, Chin, PT, et al. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett 2006, 6: 1–6.
Mulder, WJ, Castermans, K, van Beijnum, JR, Oude Egbrink, MG, Chin, PT, et al. Molecular imaging of tumor angiogenesis using alphavbeta3‐integrin targeted multimodal quantum dots. Angiogenesis 2009, 12: 17–24.
Weissleder, R, Moore, A, Mahmood, U, Bhorade, R, Benveniste, H, et al. In vivo magnetic resonance imaging of transgene expression. Nat Med 2000, 6: 351–355.
Sosnovik, DE, Schellenberger, EA, Nahrendorf, M, Novikov, MS, Matsui, T, et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto‐optical nanoparticle. Magn Reson Med 2005, 54: 718–724.
Nahrendorf, M, Jaffer, FA, Kelly, KA, Sosnovik, DE, Aikawa, E, et al. Noninvasive vascular cell adhesion molecule‐1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006, 114: 1504–1511.
Devaraj, NK, Keliher, EJ, Thurber, GM, Nahrendorf, M, Weissleder, R. 18F labeled nanoparticles for in vivo PET‐CT imaging. Bioconjug Chem 2009, 20: 397–401.
Nahrendorf, M, Zhang, H, Hembrador, S, Panizzi, P, Sosnovik, DE, et al. Nanoparticle PET‐CT imaging of macrophages in inflammatory atherosclerosis. Circulation 2008, 117: 379–387.
Koole, R, van Schooneveld, MM, Hilhorst, J, Castermans, K, Cormode, DP, et al. Paramagnetic lipid‐coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging. Bioconjug Chem 2008, 19: 2471–2479.
van Schooneveld, MM, Vucic, E, Koole, R, Zhou, Y, Stocks, J, et al. Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett 2008, 8: 2517–2525.
Kim, J, Kim, HS, Lee, N, Kim, T, Kim, H, et al. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed Engl 2008, 47: 8438–8441.
Rieter, WJ, Kim, JS, Taylor, KM, An, H, Lin, W, et al. Hybrid silica nanoparticles for multimodal imaging. Angew Chem Int Ed Engl 2007, 46: 3680–3682.
Zhang, Y, Wang, SN, Ma, S, Guan, JJ, Li, D, et al. Self‐assembly multifunctional nanocomposites with Fe3O4 magnetic core and CdSe/ZnS quantum dots shell. J Biomed Mater Res A 2008, 85: 840–846.
Cormode, DP, Skajaa, T, van Schooneveld, MM, Koole, R, Jarzyna, P, et al. Nanocrystal core high‐density lipoproteins: a multimodality contrast agent platform. Nano Lett 2008, 8: 3715–3723.
Lanza, GM, Winter, P, Caruthers, S, Schmeider, A, Crowder, K, et al. Novel paramagnetic contrast agents for molecular imaging and targeted drug delivery. Curr Pharm Biotechnol 2004, 5: 495–507.
Winter, PM, Neubauer, AM, Caruthers, SD, Harris, TD, Robertson, JD, et al. Endothelial alpha(v)beta3 integrin‐targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26: 2103–2109.
Schmieder, AH, Caruthers, SD, Zhang, H, Williams, TA, Robertson, JD, et al. Three‐dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)‐targeted theranostic nanoparticles in the MDA‐MB‐435 xenograft mouse model. FASEB J 2008, 22: 4179–4189.
Kim, J, Lee, JE, Lee, SH, Yu, JH, Lee, JH, et al. Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer‐targeted imaging and magnetically guided drug delivery. Adv Mater 2008, 20: 478.
Nasongkla, N, Bey, E, Ren, J, Ai, H, Khemtong, C, et al. Multifunctional polymeric micelles as cancer‐targeted, MRI‐ultrasensitive drug delivery systems. Nano Lett 2006, 6: 2427–2430.
Park, JH, von Maltzahn, G, Ruoslahti, E, Bhatia, SN, Sailor, MJ. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. Angew Chem Int Ed Engl 2008, 47: 7284–7288.
Liong, M, Lu, J, Kovochich, M, Xia, T, Ruehm, SG, et al. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2: 889–896.
Lai, CW, Wang, YH, Lai, CH, Yang, MJ, Chen, CY, et al. Iridium‐complex‐functionalized Fe3O4/SiO2 core/shell nanoparticles: a facile three‐in‐one system in magnetic resonance imaging, luminescence imaging, and photodynamic therapy. Small 2008, 4: 218–224.
Medarova, Z, Pham, W, Farrar, C, Petkova, V, Moore, A. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 2007, 13: 372–377.
Qi, L, Gao, X. Quantum dot‐amphipol nanocomplex for intracellular delivery and real‐time imaging of siRNA. ACS Nano 2008, 2: 1403–1410.
Lee, JS, Green, JJ, Love, KT, Sunshine, J, Langer, R, et al. Gold, poly(beta‐amino ester) nanoparticles for small interfering RNA delivery. Nano Lett 2009, 9: 2402–2406.
Bartlett, DW, Su, H, Hildebrandt, IJ, Weber, WA, Davis, ME, et al. Impact of tumor‐specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci USA 2007, 104: 15549–15554.
Lee, JH, Lee, K, Moon, SH, Lee, Y, Park, TG, et al. All‐in‐one target‐cell‐specific magnetic nanoparticles for simultaneous molecular imaging and siRNA delivery. Angew Chem Int Ed Engl 2009, 48: 4174–4179.
Lim, YT, Cho, MY, Kim, JK, Hwangbo, S, Chung, BH. Plasmonic magnetic nanostructure for bimodal imaging and photonic‐based therapy of cancer cells. Chembiochem 2007, 8: 2204–2209.
Larson, TA, Bankson, J, Aaron, J, Sokolov, K. Hybrid plasmonic magnetic nanoparticles as molecular specific agents for MRI/optical imaging and photothermal therapy of cancer cells. Nanotechnology 2007, 18: 325101/1–325101/8.
Wang, C, Chen, J, Talavage, T, Irudayaraj, J. Gold nanorod/Fe3O4 nanoparticle “nano‐pearl‐necklaces” for simultaneous targeting, dual‐mode imaging, and photothermal ablation of cancer cells. Angew Chem Int Ed Engl 2009, 48: 2759–2763.
Lim, YT, Cho, MY, Choi, BS, Lee, JM, Chung, BH. Paramagnetic gold nanostructures for dual modal bioimaging and phototherapy of cancer cells. Chem Commun (Camb) 2008, 28: 4930–4932.